Literature DB >> 27383832

Role of farnesoid X receptor in cholestasis.

Zhi Qing Yuan1, Ke Wei Li2.   

Abstract

The nuclear receptor farnesoid X receptor (FXR) plays an important role in physiological bile acid synthesis, secretion and transport. Defects of FXR regulation in these processes can cause cholestasis and subsequent pathological changes. FXR regulates the synthesis and uptake of bile acid via enzymes. It also increases bile acid solubility and elimination by promoting conjugation reactions and exports pump expression in cholestasis. The changes in bile acid transporters are involved in cholestasis, which can result from the mutations of transporter genes or acquired dysfunction of transport systems, such as inflammation-induced intrahepatic cholestasis. The modulation function of FXR in extrahepatic cholestasis is not identical to that in intrahepatic cholestasis, but the discrepancy may be reduced over time. In extrahepatic cholestasis, increasing biliary pressure can induce bile duct proliferation and bile infarcts, but the absence of FXR may ameliorate them. This review provides an update on the function of FXR in the regulation of bile acid metabolism, its role in the pathophysiological process of cholestasis and the therapeutic use of FXR agonists.
© 2016 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  bile acid; cholestasis; enterohepatic circulation; farnesoid X receptor; hepatobiliary transport

Mesh:

Substances:

Year:  2016        PMID: 27383832     DOI: 10.1111/1751-2980.12378

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  14 in total

Review 1.  Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids.

Authors:  Mohsen Mazidi; Pedro Paulo P de Caravatto; John R Speakman; Ricardo V Cohen
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

2.  Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway.

Authors:  Tianwei Zhang; Shanshan Feng; Jiahuan Li; Zhitao Wu; Qiangqiang Deng; Wei Yang; Jing Li; Guoyu Pan
Journal:  Arch Toxicol       Date:  2022-03-10       Impact factor: 6.168

3.  Role of FXR in Liver Inflammation during Nonalcoholic Steatohepatitis.

Authors:  Laura E Armstrong; Grace L Guo
Journal:  Curr Pharmacol Rep       Date:  2017-02-21

Review 4.  Mediterranean Diet: Prevention of Colorectal Cancer.

Authors:  Micah G Donovan; Ornella I Selmin; Tom C Doetschman; Donato F Romagnolo
Journal:  Front Nutr       Date:  2017-12-05

5.  Chicken bile powder protects against α-naphthylisothiocyanate-induced cholestatic liver injury in mice.

Authors:  Yi-Fei Li; Jia-Sheng Wu; Yuan-Yuan Li; Yan Dai; Min Zheng; Jia-Kai Zeng; Guo-Feng Wang; Tian-Ming Wang; Wen-Kai Li; Xue-Yan Zhang; Ming Gu; Cheng Huang; Li Yang; Zheng-Tao Wang; Yue-Ming Ma
Journal:  Oncotarget       Date:  2017-09-27

Review 6.  Update on pharmacotherapies for cholestatic liver disease.

Authors:  Ahmad H Ali; James H Tabibian; Keith D Lindor
Journal:  Hepatol Commun       Date:  2016-12-21

7.  Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis.

Authors:  Jiaxiong Ming; Qianqian Xu; Limin Gao; Yanfang Deng; Jie Yin; Qun Zhou; Qingyi Tong; Yonghui Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11

8.  Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling.

Authors:  Vik Meadows; Lindsey Kennedy; Burcin Ekser; Konstantina Kyritsi; Debjyoti Kundu; Tianhao Zhou; Lixian Chen; Linh Pham; Nan Wu; Jennifer Demieville; Laura Hargrove; Shannon Glaser; Gianfranco Alpini; Heather Francis
Journal:  Hepatology       Date:  2021-09-09       Impact factor: 17.298

Review 9.  Mechanisms of Weight Loss After Obesity Surgery.

Authors:  Elina Akalestou; Alexander D Miras; Guy A Rutter; Carel W le Roux
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 25.261

10.  Discovery of Natural Products as Novel and Potent FXR Antagonists by Virtual Screening.

Authors:  Yanyan Diao; Jing Jiang; Shoude Zhang; Shiliang Li; Lei Shan; Jin Huang; Weidong Zhang; Honglin Li
Journal:  Front Chem       Date:  2018-04-30       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.